15noEndometrial cancer is the most common gynecologic malignancy arising from the endometrium. Identification of serum biomarkers could be beneficial for its early diagnosis. We have used 2D-Difference In Gel Electrophoresis (2D-DIGE) coupled with Mass Spectrometry (MS) procedures to investigate the serum proteome of 15 patients with endometrial cancer and 15 non-cancer subjects. We have identified 16 proteins with diagnostic potential, considering only spots with a fold change in %V ≥ 1.5 or ≤0.6 in intensity, which were statistically significant (p < 0.05). Western blotting data analysis confirmed the upregulation of CLU, ITIH4, SERPINC1, and C1RL in endometrial and exosome cancer sera compared to those of control subjects. The applicatio...
Cancers can cause some proteins to be aberrantly excreted or released in the urine, which can be use...
Endometrial cancer is the most common gynaecological malignancy in developed countries. Over 382,000...
Endometrial cancer is the most common gynaecological malignancy in high-income countries and its inc...
Endometrial cancer is the most common gynecologic malignancy arising from the endometrium. Identific...
Endometrial cancer is the most common gynecologic malignancy arising from the endometrium. Identific...
Serum samples from endometrial cancer (EC) patients and healthy females were analyzed using surface-...
Simple Summary Endometrial cancers (ECs) are mostly adenocarcinomas arising from the inner part of t...
Uterine cancers are among the most prevalent gynecological malignancies, and endometrial cancer (EC)...
The present study was aimed at identifying novel proteins in endometrial cancer (EC), employing prot...
Endometrial cancer (EC) is the most common gynecologic malignancy of the endometrium. This study foc...
10noEndometrial cancer (EC) is the most frequent gynaecologic cancer in postmenopausal women. We use...
Endometriosis is a common benign gynecological disease, characterized by proliferation of functional...
Endometrial cancer (EC) is one of the most frequently diagnosed gynecological cancers worldwide, and...
Background: Abnormal uterine bleeding is the main symptom of endometrial cancer (EC), but it is high...
Endometrial cancer arises from the endometrium. It has a slow progression and a reported survival ra...
Cancers can cause some proteins to be aberrantly excreted or released in the urine, which can be use...
Endometrial cancer is the most common gynaecological malignancy in developed countries. Over 382,000...
Endometrial cancer is the most common gynaecological malignancy in high-income countries and its inc...
Endometrial cancer is the most common gynecologic malignancy arising from the endometrium. Identific...
Endometrial cancer is the most common gynecologic malignancy arising from the endometrium. Identific...
Serum samples from endometrial cancer (EC) patients and healthy females were analyzed using surface-...
Simple Summary Endometrial cancers (ECs) are mostly adenocarcinomas arising from the inner part of t...
Uterine cancers are among the most prevalent gynecological malignancies, and endometrial cancer (EC)...
The present study was aimed at identifying novel proteins in endometrial cancer (EC), employing prot...
Endometrial cancer (EC) is the most common gynecologic malignancy of the endometrium. This study foc...
10noEndometrial cancer (EC) is the most frequent gynaecologic cancer in postmenopausal women. We use...
Endometriosis is a common benign gynecological disease, characterized by proliferation of functional...
Endometrial cancer (EC) is one of the most frequently diagnosed gynecological cancers worldwide, and...
Background: Abnormal uterine bleeding is the main symptom of endometrial cancer (EC), but it is high...
Endometrial cancer arises from the endometrium. It has a slow progression and a reported survival ra...
Cancers can cause some proteins to be aberrantly excreted or released in the urine, which can be use...
Endometrial cancer is the most common gynaecological malignancy in developed countries. Over 382,000...
Endometrial cancer is the most common gynaecological malignancy in high-income countries and its inc...